Organism name | Posidonia oceanica |
---|---|
Genus | Posidonia |
Family | Posidoniaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Posidonia oceanica |
---|---|
Linked NCBI taxonomy ID | 55489 |
Linked level | species |
Family in NCBI taxonomy | Posidoniaceae |
---|---|
ID | 55435 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | Liliopsida |
---|---|
ID | 4447 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00002668
![]() |
Protocatechuic acid
/ 3,4-Dihydroxybenzoic acid |
CHEMBL37537
|
C009091
|
33 / 19 / 19 | 2 / 0 | No. 817 | No. 81 |
![]() |
C00000856
![]() |
4-Hydroxybenzoic acid
/ p-Hydroxybenzoic acid |
CHEMBL441343
|
C038193
|
21 / 7 / 16 | 2 / 1 | No. 817 | No. 81 |
![]() |
C00002647
![]() |
Gallic acid
|
CHEMBL288114
|
D005707
|
42 / 53 / 68 | 52 / 16 | No. 817 | No. 81 |
![]() |
C00007558
![]() |
Syringaldehyde
/ 4-Hydroxy-3,5-dimethoxybenzaldehyde |
CHEMBL225303
|
C069665
|
No. 856 |
![]() |
|||
C00000615
![]() |
Caffeic acid
|
CHEMBL145
CHEMBL1320034 |
68 / 64 / 63 | No. 904 | No. 6 |
![]() |
||
C00029961
![]() |
Cinnamic acid
/ .beta-Phenylacrylic acid |
CHEMBL27246
|
C029010
|
5 / 2 / 2 | 16 / 2 | No. 904 | No. 6 |
![]() |
C00002683
![]() |
Vanillin
|
CHEMBL13883
|
18 / 8 / 9 | No. 1003 |
![]() |
|||
C00002682
![]() |
Vanillic acid
/ 3-Methoxy-4-hydroxybenzoic acid |
CHEMBL120568
|
D014641
|
5 / 3 / 3 | 5 / 0 | No. 1073 |
![]() |
|
C00002674
![]() |
Syringic acid
/ 4-Hydroxy-3,5-dimethoxybenzoic acid |
CHEMBL1414
|
C001945
|
12 / 3 / 5 | No. 1073 |
![]() |
||
C00002686
![]() |
Acetosyringone
|
CHEMBL224146
|
C051667
|
3 / 11 / 10 | No. 1180 |
![]() |
||
C00002776
![]() |
Sinapic acid
|
CHEMBL109341
|
C073734
|
5 / 5 / 5 | 0 / 5 | No. 1366 | No. 6 |
![]() |
C00002743
![]() |
Ferulic acid
/ 3-(4-Hydroxy-3-methoxyphenyl)-2-propenoic acid |
CHEMBL32749
|
C004999
|
110 / 52 / 40 | 16 / 6 | No. 1366 | No. 6 |
![]() |
C00002689
![]() |
Apocynin
/ Acetovanillone |
CHEMBL346919
|
C056165
|
2 / 0 / 0 | 43 / 10 | No. 1494 |
![]() |
|
C00002670
![]() |
Pyrogallol
|
CHEMBL307145
|
D011748
|
115 / 69 / 60 | 8 / 2 | No. 1590 | No. 82 |
![]() |
C00002644
![]() |
Catechol
/ Pyrocatechol |
CHEMBL280998
|
C034221
|
148 / 82 / 64 | 22 / 5 | No. 1590 | No. 82 |
![]() |
C00002665
![]() |
Phloroglucinol
|
CHEMBL473159
|
D010696
|
3 / 4 / 2 | 8 / 2 | No. 1590 | No. 82 |
![]() |
C00002657
![]() |
p-Formylphenol
/ 4-Hydroxybenzaldehyde / p-Hydroxybenzaldehyde |
CHEMBL14193
|
C011483
|
3 / 2 / 2 | No. 2076 |
![]() |
||
C00018099
![]() |
Catechaldehyde
/ Protocatechualdehyde / 3,4-Dihydroxybenzaldehyde |
CHEMBL222021
|
C005581
|
7 / 0 / 0 | 5 / 2 | No. 2076 |
![]() |
|
C00000207
![]() |
Benzoic acid
|
CHEMBL541
|
D019817
|
97 / 39 / 33 | 24 / 1 | No. 2192 |
![]() |
|
C00029536
![]() |
p-Anisic acid
/ 4-Methoxybenzoic acid |
CHEMBL21932
|
C004520
|
3 / 2 / 3 | No. 2930 |
![]() |
||
C00002664
![]() |
Phenol
|
CHEMBL14060
|
D019800
|
111 / 52 / 47 | 101 / 30 | No. 6006 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P00918 | Carbonic anhydrase 2 | Lyase | C00000207 C00000615 C00000856 C00002644 C00002647 C00002664 C00002668 C00002670 C00002674 C00002743 C00029536 | 1 / 2 |
P00915 | Carbonic anhydrase 1 | Lyase | C00000615 C00000856 C00002644 C00002647 C00002664 C00002668 C00002670 C00002674 C00002743 C00029536 | 0 / 0 |
P03372 | Estrogen receptor | NR3A1 | C00000207 C00000615 C00002644 C00002647 C00002664 C00002668 C00002670 C00002682 C00002743 C00029961 | 1 / 1 |
O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00000615 C00002644 C00002647 C00002668 C00002670 C00002683 C00002686 C00002776 C00018099 | 0 / 0 |
P23280 | Carbonic anhydrase 6 | Lyase | C00000615 C00000856 C00002644 C00002647 C00002664 C00002668 C00002670 C00002674 C00002743 | 0 / 0 |
P22748 | Carbonic anhydrase 4 | Lyase | C00000615 C00000856 C00002644 C00002647 C00002664 C00002668 C00002674 C00002743 | 1 / 1 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00000207 C00000615 C00002644 C00002647 C00002664 C00002670 C00002743 C00002776 | 0 / 3 |
O43570 | Carbonic anhydrase 12 | Lyase | C00000615 C00000856 C00002644 C00002647 C00002664 C00002668 C00002674 C00002743 | 1 / 2 |
P43166 | Carbonic anhydrase 7 | Lyase | C00000615 C00000856 C00002644 C00002647 C00002664 C00002668 C00002674 C00002743 | 0 / 0 |
Q16790 | Carbonic anhydrase 9 | Lyase | C00000615 C00000856 C00002644 C00002647 C00002664 C00002668 C00002674 C00002743 | 0 / 1 |
Q9ULX7 | Carbonic anhydrase 14 | Lyase | C00000615 C00000856 C00002644 C00002647 C00002664 C00002668 C00002674 C00002743 | 0 / 0 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00000207 C00000615 C00002644 C00002664 C00002670 C00002743 C00002776 | 0 / 0 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00000207 C00000615 C00000856 C00002644 C00002664 C00002670 C00002743 | 1 / 8 |
P03956 | Interstitial collagenase | M10A | C00000207 C00000615 C00002644 C00002664 C00002668 C00002670 C00002743 | 0 / 1 |
Q9Y2D0 | Carbonic anhydrase 5B, mitochondrial | Lyase | C00000615 C00000856 C00002644 C00002647 C00002664 C00002674 C00002743 | 0 / 0 |
P35218 | Carbonic anhydrase 5A, mitochondrial | Lyase | C00000615 C00000856 C00002644 C00002647 C00002664 C00002674 C00002743 | 0 / 0 |
P14780 | Matrix metalloproteinase-9 | M10A | C00000207 C00000615 C00002644 C00002664 C00002668 C00002670 C00002743 | 2 / 2 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00000207 C00000615 C00002644 C00002647 C00002664 C00002670 C00002743 | 0 / 0 |
P07451 | Carbonic anhydrase 3 | Lyase | C00000615 C00000856 C00002644 C00002647 C00002664 C00002674 C00002743 | 0 / 0 |
P15121 | Aldose reductase | Enzyme | C00000615 C00002647 C00002668 C00002674 C00002682 C00029961 | 0 / 0 |
P04150 | Glucocorticoid receptor | NR3C1 | C00000207 C00002644 C00002647 C00002664 C00002670 C00002743 | 0 / 1 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00000207 C00000615 C00002644 C00002664 C00002670 C00002743 | 0 / 0 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00000615 C00002644 C00002647 C00002668 C00002743 C00018099 | 0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00000207 C00000615 C00002644 C00002664 C00002670 C00002743 | 0 / 1 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00000615 C00002644 C00002647 C00002664 C00002670 C00002683 | 1 / 1 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00000207 C00000615 C00002644 C00002664 C00002670 C00002743 | 1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00000207 C00000615 C00002644 C00002664 C00002670 C00002743 | 0 / 1 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00000207 C00000615 C00002644 C00002664 C00002670 C00002743 | 2 / 2 |
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00000207 C00000615 C00002644 C00002664 C00002670 C00002743 | 1 / 0 |
P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00000207 C00002644 C00002664 C00002670 C00002743 | 0 / 0 |
P29466 | Caspase-1 | C14 | C00000207 C00002644 C00002664 C00002670 C00002743 | 0 / 0 |
P17252 | Protein kinase C alpha type | Alpha | C00000207 C00002644 C00002664 C00002670 C00002743 | 0 / 0 |
P27361 | Mitogen-activated protein kinase 3 | Erk | C00000207 C00002644 C00002664 C00002670 C00002743 | 0 / 0 |
P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00000207 C00002644 C00002664 C00002670 C00002743 | 1 / 0 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00000207 C00002644 C00002664 C00002670 C00002743 | 0 / 0 |
O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00000207 C00002644 C00002664 C00002670 C00002743 | 0 / 0 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00000615 C00002644 C00002647 C00002670 C00018099 | 0 / 0 |
P35372 | Mu-type opioid receptor | Opioid receptor | C00000207 C00002644 C00002664 C00002670 C00002743 | 0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | C00000615 C00002644 C00002647 C00002670 C00002686 | 11 / 10 |
P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00000207 C00002644 C00002664 C00002670 C00002743 | 0 / 0 |
P25103 | Substance-P receptor | Neurokinin receptor | C00000207 C00002644 C00002664 C00002670 C00002743 | 0 / 0 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00000615 C00002644 C00002647 C00002665 C00002670 | 0 / 0 |
P25105 | Platelet-activating factor receptor | PAF receptor | C00000207 C00002644 C00002664 C00002670 C00002743 | 0 / 0 |
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00000615 C00002644 C00002647 C00002670 C00002683 | 2 / 2 |
P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00000207 C00002644 C00002664 C00002670 C00002743 | 0 / 0 |
P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00000207 C00002644 C00002664 C00002670 C00002743 | 0 / 1 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00000207 C00002644 C00002664 C00002670 C00002743 | 1 / 1 |
P25021 | Histamine H2 receptor | Histamine receptor | C00000207 C00002644 C00002664 C00002670 C00002743 | 0 / 0 |
P35367 | Histamine H1 receptor | Histamine receptor | C00000207 C00002644 C00002664 C00002670 C00002743 | 0 / 0 |
Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00000207 C00002644 C00002664 C00002670 C00002743 | 1 / 0 |
P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00000207 C00002644 C00002664 C00002670 C00002743 | 0 / 0 |
P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00000207 C00002644 C00002664 C00002670 C00002743 | 0 / 0 |
P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00000207 C00002644 C00002664 C00002670 C00002743 | 0 / 0 |
P22303 | Acetylcholinesterase | Hydrolase | C00000207 C00002644 C00002664 C00002670 C00002743 | 1 / 0 |
P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00000207 C00002644 C00002664 C00002670 C00002743 | 2 / 1 |
P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00000207 C00002644 C00002664 C00002670 C00002743 | 1 / 0 |
P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00000207 C00002644 C00002664 C00002670 C00002743 | 0 / 0 |
P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00000207 C00002644 C00002664 C00002670 C00002743 | 3 / 0 |
P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00000207 C00002644 C00002664 C00002670 C00002743 | 0 / 0 |
P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00000207 C00002644 C00002664 C00002670 C00002743 | 0 / 0 |
P06241 | Tyrosine-protein kinase Fyn | Src | C00000207 C00002644 C00002664 C00002670 C00002743 | 0 / 0 |
Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00000207 C00002644 C00002664 C00002670 C00002743 | 0 / 0 |
P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00000207 C00002644 C00002664 C00002670 C00002743 | 0 / 0 |
P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00000207 C00002644 C00002664 C00002670 C00002743 | 0 / 0 |
P21452 | Substance-K receptor | Neurokinin receptor | C00000207 C00002644 C00002664 C00002670 C00002743 | 0 / 0 |
P06239 | Tyrosine-protein kinase Lck | Src | C00000207 C00002644 C00002664 C00002670 C00002743 | 0 / 1 |
P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00000207 C00002644 C00002664 C00002670 C00002743 | 1 / 0 |
P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00000207 C00002644 C00002664 C00002670 C00002743 | 5 / 9 |
P31645 | Sodium-dependent serotonin transporter | Serotonin | C00000207 C00002644 C00002664 C00002670 C00002743 | 2 / 0 |
P14416 | D(2) dopamine receptor | Dopamine receptor | C00000207 C00002644 C00002664 C00002670 C00002743 | 2 / 0 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | C00000207 C00002644 C00002664 C00002670 C00002743 | 0 / 0 |
P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00000207 C00002644 C00002664 C00002670 C00002743 | 0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | C00000207 C00002644 C00002664 C00002670 C00002743 | 0 / 0 |
Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00000207 C00002644 C00002664 C00002670 C00002743 | 0 / 0 |
P29274 | Adenosine receptor A2a | Adenosine receptor | C00000207 C00002644 C00002664 C00002670 C00002743 | 0 / 0 |
Q13093 | Platelet-activating factor acetylhydrolase | Enzyme | C00000615 C00002647 C00002668 C00002743 C00002776 | 3 / 0 |
P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00000207 C00002644 C00002664 C00002670 C00002743 | 0 / 0 |
P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00000207 C00002644 C00002664 C00002670 C00002743 | 1 / 1 |
P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00000207 C00002644 C00002664 C00002670 C00002743 | 1 / 1 |
P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00000207 C00002644 C00002664 C00002670 C00002743 | 0 / 0 |
P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00000207 C00002644 C00002664 C00002670 C00002743 | 1 / 0 |
P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00000207 C00002644 C00002664 C00002670 C00002743 | 0 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00000615 C00002644 C00002647 C00002670 C00002683 | 0 / 0 |
P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00000207 C00002644 C00002664 C00002670 C00002743 | 0 / 0 |
P30542 | Adenosine receptor A1 | Adenosine receptor | C00000207 C00002644 C00002664 C00002670 C00002743 | 0 / 0 |
P33765 | Adenosine receptor A3 | Adenosine receptor | C00000207 C00002644 C00002664 C00002670 C00002743 | 0 / 0 |
P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00000207 C00002644 C00002664 C00002670 C00002743 | 0 / 0 |
P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00000207 C00002644 C00002664 C00002670 C00002743 | 1 / 0 |
P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00000207 C00002644 C00002664 C00002670 C00002743 | 1 / 1 |
P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00000207 C00002644 C00002664 C00002670 C00002743 | 0 / 0 |
P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00000207 C00002644 C00002664 C00002670 C00002743 | 2 / 0 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00002644 C00002647 C00002664 C00002670 C00002683 | 0 / 0 |
P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00000207 C00002644 C00002664 C00002670 C00002743 | 0 / 0 |
P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00000207 C00002644 C00002664 C00002670 C00002743 | 0 / 0 |
O75496 | Geminin | Unclassified protein | C00002644 C00002668 C00002686 C00002689 C00002743 | 0 / 0 |
Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00000207 C00002644 C00002664 C00002670 C00002743 | 1 / 0 |
P08311 | Cathepsin G | S1A | C00000207 C00002644 C00002664 C00002670 C00002743 | 0 / 0 |
P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00000207 C00002644 C00002664 C00002670 C00002743 | 0 / 0 |
P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00000207 C00002644 C00002664 C00002670 C00002743 | 0 / 0 |
P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00000207 C00002644 C00002664 C00002670 C00002743 | 0 / 0 |
P21917 | D(4) dopamine receptor | Dopamine receptor | C00000207 C00002644 C00002664 C00002670 C00002743 | 0 / 0 |
P30988 | Calcitonin receptor | Calcitonin receptor | C00000207 C00002644 C00002664 C00002670 C00002743 | 0 / 0 |
P35462 | D(3) dopamine receptor | Dopamine receptor | C00000207 C00002644 C00002664 C00002670 C00002743 | 1 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | C00000207 C00002644 C00002664 C00002670 C00002743 | 0 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | C00000207 C00002644 C00002664 C00002670 C00002743 | 0 / 1 |
P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00000207 C00002644 C00002664 C00002670 C00002743 | 0 / 0 |
P08246 | Neutrophil elastase | S1A | C00000207 C00002644 C00002664 C00002670 C00002743 | 2 / 1 |
P25101 | Endothelin-1 receptor | Endothelin receptor | C00000207 C00002644 C00002664 C00002670 C00002743 | 0 / 0 |
P30411 | B2 bradykinin receptor | Bradykinin receptor | C00000207 C00002644 C00002664 C00002670 C00002743 | 0 / 0 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | C00000207 C00002644 C00002664 C00002670 C00002743 | 0 / 0 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00000207 C00002644 C00002664 C00002670 C00002743 | 0 / 0 |
P14679 | Tyrosinase | Oxidoreductase | C00000615 C00002665 C00002670 C00002743 | 4 / 2 |
P47989 | Xanthine dehydrogenase/oxidase | Oxidoreductase | C00000615 C00002644 C00002743 C00029961 | 1 / 1 |
P19224 | UDP-glucuronosyltransferase 1-6 | Enzyme | C00000207 C00000856 C00002664 C00002683 | 0 / 0 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00000615 C00002644 C00002647 C00002670 | 3 / 3 |
Q9UNA4 | DNA polymerase iota | Enzyme | C00002644 C00002668 C00002682 C00018099 | 0 / 0 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00000615 C00002644 C00002647 C00002670 | 0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00000615 C00002644 C00002647 C00002668 | 4 / 3 |
P08253 | 72 kDa type IV collagenase | M10A | C00000615 C00002644 C00002668 | 1 / 3 |
O75164 | Lysine-specific demethylase 4A | Enzyme | C00000615 C00002644 C00018099 | 0 / 0 |
P51649 | Succinate-semialdehyde dehydrogenase, mitochondrial | Oxidoreductase | C00000856 C00002657 C00002683 | 1 / 1 |
P22309 | UDP-glucuronosyltransferase 1-1 | Enzyme | C00002647 C00002670 C00002743 | 5 / 1 |
P09917 | Arachidonate 5-lipoxygenase | Oxidoreductase | C00000615 C00002644 C00002668 | 0 / 0 |
O60656 | UDP-glucuronosyltransferase 1-9 | Enzyme | C00000207 C00000856 C00002683 | 0 / 0 |
P51580 | Thiopurine S-methyltransferase | Enzyme | C00000856 C00002682 C00029536 | 1 / 1 |
P14151 | L-selectin | Adhesion | C00002647 C00002668 C00002670 | 0 / 0 |
P10275 | Androgen receptor | NR3C4 | C00002664 C00002670 C00002683 | 3 / 4 |
Q8TDS4 | Hydroxycarboxylic acid receptor 2 | Hydroxycarboxylic acid receptor | C00000615 C00002743 C00029961 | 0 / 0 |
P16109 | P-selectin | Adhesion | C00002647 C00002668 C00002670 | 1 / 0 |
P16581 | E-selectin | Adhesion | C00002647 C00002668 C00002670 | 0 / 0 |
P06746 | DNA polymerase beta | Enzyme | C00000615 C00002644 C00002668 | 0 / 0 |
Q9GZT9 | Egl nine homolog 1 | Enzyme | C00000615 C00002644 C00002668 | 1 / 1 |
P80404 | 4-aminobutyrate aminotransferase, mitochondrial | Transferase | C00000856 C00002657 C00002683 | 1 / 1 |
P10145 | Interleukin-8 | Secreted protein | C00002644 C00002647 C00002670 | 0 / 0 |
Q9HAW7 | UDP-glucuronosyltransferase 1-7 | Enzyme | C00000856 C00002683 | 0 / 0 |
P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | C00002644 C00002664 | 5 / 3 |
P11473 | Vitamin D3 receptor | NR1I1 | C00002647 C00002670 | 2 / 3 |
P08254 | Stromelysin-1 | M10A | C00002644 C00002668 | 1 / 0 |
P18031 | Tyrosine-protein phosphatase non-receptor type 1 | Tyr | C00000615 C00029961 | 0 / 0 |
P06280 | Alpha-galactosidase A | Enzyme | C00000615 C00002664 | 1 / 1 |
Q96RI1 | Bile acid receptor | NR1H4 | C00002644 C00002683 | 0 / 0 |
Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | C00000615 C00002644 | 0 / 0 |
Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00000615 C00018099 | 0 / 0 |
Q12794 | Hyaluronidase-1 | Enzyme | C00000615 C00002743 | 1 / 2 |
Q16637 | Survival motor neuron protein | Unclassified protein | C00002644 C00002647 | 4 / 1 |
P02768 | Serum albumin | Secreted protein | C00002668 C00002670 | 0 / 0 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00002644 C00002670 | 0 / 0 |
P34969 | 5-hydroxytryptamine receptor 7 | Serotonin receptor | C00002683 C00002743 | 0 / 0 |
Q9HAW8 | UDP-glucuronosyltransferase 1-10 | Enzyme | C00000856 C00002683 | 0 / 0 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | C00002644 C00002689 | 0 / 0 |
Q9Y468 | Lethal(3)malignant brain tumor-like protein 1 | Unclassified protein | C00002644 C00002668 | 0 / 0 |
P10253 | Lysosomal alpha-glucosidase | Hydrolase | C00000615 C00002668 | 1 / 1 |
P51151 | Ras-related protein Rab-9A | Unclassified protein | C00002644 C00018099 | 0 / 0 |
P19793 | Retinoic acid receptor RXR-alpha | NR2B1 | C00002664 C00002683 | 0 / 0 |
Q01453 | Peripheral myelin protein 22 | Unclassified protein | C00000615 C00002644 | 5 / 2 |
P54855 | UDP-glucuronosyltransferase 2B15 | Enzyme | C00002670 C00002743 | 0 / 0 |
P16473 | Thyrotropin receptor | Glycohormone receptor | C00000207 C00000615 | 3 / 2 |
P46063 | ATP-dependent DNA helicase Q1 | Enzyme | C00002644 C00002670 | 0 / 0 |
Q13951 | Core-binding factor subunit beta | Unclassified protein | C00002668 C00002670 | 0 / 1 |
P22894 | Neutrophil collagenase | M10A | C00002644 C00002668 | 0 / 0 |
Q01196 | Runt-related transcription factor 1 | Unclassified protein | C00002668 C00002670 | 1 / 4 |
Q9UQ49 | Sialidase-3 | Enzyme | C00000207 C00000856 | 0 / 0 |
P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | C00000615 C00002644 | 0 / 0 |
P12821 | Angiotensin-converting enzyme | M2 | C00002647 | 4 / 2 |
O94956 | Solute carrier organic anion transporter family member 2B1 | Unclassified protein | C00000207 | 0 / 0 |
Q9Y4X1 | UDP-glucuronosyltransferase 2A1 | Enzyme | C00002683 | 0 / 0 |
Q9HAW9 | UDP-glucuronosyltransferase 1-8 | Enzyme | C00000856 | 0 / 0 |
P51449 | Nuclear receptor ROR-gamma | Nuclear hormone receptor subfamily 1 group F member 3 | C00002644 | 0 / 0 |
O15118 | Niemann-Pick C1 protein | Unclassified protein | C00002644 | 1 / 1 |
Q04828 | Aldo-keto reductase family 1 member C1 | Enzyme | C00000615 | 0 / 0 |
Q99700 | Ataxin-2 | Unclassified protein | C00002644 | 1 / 1 |
P56817 | Beta-secretase 1 | A1A | C00002665 | 0 / 0 |
P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00002644 | 2 / 0 |
P35236 | Tyrosine-protein phosphatase non-receptor type 7 | Tyr | C00000615 | 0 / 0 |
P08581 | Hepatocyte growth factor receptor | TK tyrosine-protein kinase MET subfamily | C00002647 | 2 / 3 |
O60218 | Aldo-keto reductase family 1 member B10 | Enzyme | C00000615 | 0 / 0 |
P11021 | 78 kDa glucose-regulated protein | Unclassified protein | C00002644 | 0 / 0 |
Q9HC16 | DNA dC->dU-editing enzyme APOBEC-3G | Enzyme | C00002644 | 0 / 0 |
Q9Y253 | DNA polymerase eta | Enzyme | C00002644 | 1 / 1 |
P52895 | Aldo-keto reductase family 1 member C2 | Enzyme | C00000615 | 1 / 0 |
Q9GZT4 | Serine racemase | Enzyme | C00000207 | 0 / 0 |
O00519 | Fatty-acid amide hydrolase 1 | Enzyme | C00002683 | 0 / 0 |
P07711 | Cathepsin L1 | C1A | C00002668 | 0 / 0 |
P42858 | Huntingtin | Unclassified protein | C00002682 | 1 / 1 |
Q99549 | M-phase phosphoprotein 8 | Unclassified protein | C00002644 | 0 / 0 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00002647 | 0 / 0 |
P39748 | Flap endonuclease 1 | Enzyme | C00002644 | 0 / 0 |
P14902 | Indoleamine 2,3-dioxygenase 1 | Enzyme | C00002657 | 0 / 0 |
P42330 | Aldo-keto reductase family 1 member C3 | Enzyme | C00000615 | 0 / 0 |
P17516 | Aldo-keto reductase family 1 member C4 | Enzyme | C00000615 | 1 / 0 |
P17405 | Sphingomyelin phosphodiesterase | Enzyme | C00002776 | 2 / 2 |
P78527 | DNA-dependent protein kinase catalytic subunit | Atypical serine/threonine protein kinase PIKK subfamily | C00002683 | 0 / 0 |
O15296 | Arachidonate 15-lipoxygenase B | Enzyme | C00002644 | 0 / 0 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | C00002647 | 7 / 37 |
P54132 | Bloom syndrome protein | Enzyme | C00002644 | 1 / 2 |
P14920 | D-amino-acid oxidase | Enzyme | C00000207 | 0 / 0 |
P78536 | Disintegrin and metalloproteinase domain-containing protein 17 | M12B | C00002647 | 1 / 0 |
P04066 | Tissue alpha-L-fucosidase | Enzyme | C00002664 | 1 / 2 |
P51452 | Dual specificity protein phosphatase 3 | Ser_Thr_Tyr | C00000615 | 0 / 0 |
P10828 | Thyroid hormone receptor beta | NR1A2 | C00000615 | 3 / 1 |
P24298 | Alanine aminotransferase 1 | Enzyme | C00000615 | 0 / 0 |
P22310 | UDP-glucuronosyltransferase 1-4 | Enzyme | C00002743 | 3 / 0 |
Q99489 | D-aspartate oxidase | Enzyme | C00000207 | 0 / 0 |
P40225 | Thrombopoietin | Unclassified protein | C00002644 | 1 / 1 |
Q8N1Q1 | Carbonic anhydrase 13 | Lyase | C00002664 | 0 / 0 |
P42345 | Serine/threonine-protein kinase mTOR | Enzyme | C00002644 | 0 / 0 |
O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | C00002644 | 1 / 0 |
O00255 | Menin | Unclassified protein | C00000615 | 2 / 5 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00000615 | 1 / 2 |
Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00002644 | 0 / 0 |
P04406 | Glyceraldehyde-3-phosphate dehydrogenase | Enzyme | C00002647 | 0 / 0 |
P07900 | Heat shock protein HSP 90-alpha | Other cytosolic protein | C00000615 | 0 / 0 |
P08238 | Heat shock protein HSP 90-beta | Other cytosolic protein | C00000615 | 0 / 0 |
P18507 | Gamma-aminobutyric acid receptor subunit gamma-2 | GABA-A gamma | C00002664 | 4 / 2 |
P47870 | Gamma-aminobutyric acid receptor subunit beta-2 | GABA-A beta | C00002664 | 0 / 0 |
P14867 | Gamma-aminobutyric acid receptor subunit alpha-1 | GABA-A alpha | C00002664 | 1 / 1 |
Q06124 | Tyrosine-protein phosphatase non-receptor type 11 | Tyr | C00000615 | 4 / 2 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00002644
C00002647
C00002665
C00002670
C00002689 |
4846 | NOS3, ECNOS, eNOS | nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) |
C00000207
C00002682
C00002689
C00029961
|
3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00002644
C00002647
C00002664
C00002689
|
5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00002647
C00002689
C00002743
|
6347 | CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, SCYA2, SMC-CF | chemokine (C-C motif) ligand 2 |
C00002644
C00002664
C00002689
|
5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00002647
C00002689
C00002743
|
5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00002647
C00002689
C00002743
|
1728 | NQO1, DHQU, DIA4, DTD, NMOR1, NMORI, QR1 | NAD(P)H dehydrogenase, quinone 1 (EC:1.6.5.2) |
C00000207
C00002644
C00002664
|
1312 | COMT | catechol-O-methyltransferase (EC:2.1.1.6) |
C00002644
C00002668
C00002670
|
6817 | SULT1A1, HAST1/HAST2, P-PST, PST, ST1A1, ST1A3, STP, STP1, TSPST1 | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 (EC:2.8.2.1) |
C00000856
C00002644
C00002647
|
1571 | CYP2E1, CPE1, CYP2E, P450-J, P450C2E | cytochrome P450, family 2, subfamily E, polypeptide 1 (EC:1.14.13.n7) |
C00002644
C00002664
C00029961
|
3162 | HMOX1, HMOX1D, HO-1, HSP32, bK286B10 | heme oxygenase (decycling) 1 (EC:1.14.99.3) |
C00000207
C00002664
C00002689
|
54575 | UGT1A10, UDPGT, UGT-1J, UGT1-10, UGT1.10, UGT1J | UDP glucuronosyltransferase 1 family, polypeptide A10 (EC:2.4.1.17) |
C00002682
C00002743
C00029961
|
54659 | UGT1A3, UDPGT, UDPGT_1-3, UGT-1C, UGT1-03, UGT1.3, UGT1C | UDP glucuronosyltransferase 1 family, polypeptide A3 (EC:2.4.1.17) |
C00002682
C00002743
C00029961
|
54577 | UGT1A7, UDPGT, UDPGT_1-7, UGT-1G, UGT1-07, UGT1.7, UGT1G | UDP glucuronosyltransferase 1 family, polypeptide A7 (EC:2.4.1.17) |
C00002682
C00002743
C00029961
|
54576 | UGT1A8, UDPGT, UDPGT_1-8, UGT-1H, UGT1-08, UGT1.8, UGT1A8S, UGT1H | UDP glucuronosyltransferase 1 family, polypeptide A8 (EC:2.4.1.17) |
C00002682
C00002743
C00029961
|
7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00002647
C00002664
C00002689
|
1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00002647
C00002743
|
581 | BAX, BCL2L4 | BCL2-associated X protein |
C00002647
C00002665
|
207 | AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) |
C00002647
C00002665
|
841 | CASP8, ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5 | caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) |
C00002647
C00002670
|
596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00002647
C00002665
|
7082 | TJP1, ZO-1 | tight junction protein 1 |
C00002664
C00002689
|
5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00002647
C00002689
|
5601 | MAPK9, JNK-55, JNK2, JNK2A, JNK2ALPHA, JNK2B, JNK2BETA, PRKM9, SAPK, SAPK1a, p54a, p54aSAPK | mitogen-activated protein kinase 9 (EC:2.7.11.24) |
C00002647
C00002689
|
5599 | MAPK8, JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1, SAPK1c | mitogen-activated protein kinase 8 (EC:2.7.11.24) |
C00002647
C00002689
|
3569 | IL6, BSF2, HGF, HSF, IFNB2, IL-6 | interleukin 6 (interferon, beta 2) |
C00002647
C00002689
|
3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00002664
C00002689
|
7299 | TYR, ATN, CMM8, OCA1, OCA1A, OCAIA, SHEP3 | tyrosinase (EC:1.14.18.1) |
C00002743
C00029961
|
54205 | CYCS, CYC, HCS, THC4 | cytochrome c, somatic |
C00002647
C00002670
|
7037 | TFRC, CD71, T9, TFR, TFR1, TR, TRFR, p90 | transferrin receptor |
C00002644
C00002664
|
5591 | PRKDC, DNA-PKcs, DNAPK, DNPK1, HYRC, HYRC1, XRCC7, p350 | protein kinase, DNA-activated, catalytic polypeptide (EC:2.7.11.1) |
C00002647
C00002664
|
6622 | SNCA, NACP, PARK1, PARK4, PD1 | synuclein, alpha (non A4 component of amyloid precursor) |
C00002647
C00002670
|
1544 | CYP1A2, CP12, P3-450, P450(PA) | cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) |
C00002664
C00002743
|
4609 | MYC, MRTL, MYCC, bHLHe39, c-Myc | v-myc avian myelocytomatosis viral oncogene homolog |
C00002644
C00002664
|
1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00002664
C00002743
|
7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00002647
C00002670
|
6356 | CCL11, SCYA11 | chemokine (C-C motif) ligand 11 |
C00002644
C00002689
|
7296 | TXNRD1, GRIM-12, TR, TR1, TRXR1, TXNR | thioredoxin reductase 1 (EC:1.8.1.9) |
C00000207
C00002664
|
3145 | HMBS, PBG-D, PBGD, PORC, UPS | hydroxymethylbilane synthase (EC:2.5.1.61) |
C00002644
C00002664
|
3043 | HBB, CD113t-C, beta-globin | hemoglobin, beta |
C00002644
C00002664
|
6352 | CCL5, D17S136E, RANTES, SCYA5, SIS-delta, SISd, TCP228, eoCP | chemokine (C-C motif) ligand 5 |
C00002644
C00002689
|
2623 | GATA1, ERYF1, GATA-1, GF-1, GF1, NF-E1, NFE1, XLANP, XLTDA, XLTT | GATA binding protein 1 (globin transcription factor 1) |
C00002644
C00002664
|
10440 | TIMM17A, TIM17, TIM17A | translocase of inner mitochondrial membrane 17 homolog A (yeast) |
C00002664
|
6348 | CCL3, G0S19-1, LD78ALPHA, MIP-1-alpha, MIP1A, SCYA3 | chemokine (C-C motif) ligand 3 |
C00002644
|
3586 | IL10, CSIF, GVHDS, IL-10, IL10A, TGIF | interleukin 10 |
C00002644
|
840 | CASP7, CASP-7, CMH-1, ICE-LAP3, LICE2, MCH3 | caspase 7, apoptosis-related cysteine peptidase (EC:3.4.22.60) |
C00002644
|
212 | ALAS2, ALAS-E, ALASE, ANH1, ASB, XLDPP, XLEPP, XLSA | aminolevulinate, delta-, synthase 2 (EC:2.3.1.37) |
C00002644
|
3284 | HSD3B2, HSD3B, HSDB, SDR11E2 | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 (EC:1.1.1.145 5.3.3.1) |
C00029961
|
338442 | HCAR2, GPR109A, HCA2, HM74a, HM74b, NIACR1, PUMAG, Puma-g | hydroxycarboxylic acid receptor 2 |
C00029961
|
6799 | SULT1A2, HAST4, P-PST, ST1A2, STP2, TSPST2 | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2 (EC:2.8.2.1) |
C00002644
|
6818 | SULT1A3, HAST, HAST3, M-PST, ST1A3/ST1A4, ST1A5, STM, TL-PST | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3 (EC:2.8.2.1) |
C00002644
|
6819 | SULT1C2, ST1C1, ST1C2, SULT1C1, humSULTC2 | sulfotransferase family, cytosolic, 1C, member 2 (EC:2.8.2.-) |
C00002644
|
1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) |
C00029961
|
3952 | LEP, LEPD, OB, OBS | leptin |
C00000856
|
183 | AGT, ANHU, SERPINA8 | angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
C00002689
|
1386 | ATF2, CRE-BP1, CREB2, HB16, TREB7 | activating transcription factor 2 (EC:2.3.1.48) |
C00002689
|
6362 | CCL18, AMAC-1, AMAC1, CKb7, DC-CK1, DCCK1, MIP-4, PARC, SCYA18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) |
C00002689
|
6354 | CCL7, FIC, MARC, MCP-3, MCP3, NC28, SCYA6, SCYA7 | chemokine (C-C motif) ligand 7 |
C00002689
|
948 | CD36, BDPLT10, CHDS7, FAT, GP3B, GP4, GPIV, PASIV, SCARB3 | CD36 molecule (thrombospondin receptor) |
C00002689
|
1437 | CSF2, GMCSF | colony stimulating factor 2 (granulocyte-macrophage) |
C00002689
|
2919 | CXCL1, FSP, GRO1, GROa, MGSA, MGSA-a, NAP-3, SCYB1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
C00002689
|
3627 | CXCL10, C7, IFI10, INP10, IP-10, SCYB10, crg-2, gIP-10, mob-1 | chemokine (C-X-C motif) ligand 10 |
C00002689
|
1536 | CYBB, AMCBX2, CGD, GP91-1, GP91-PHOX, GP91PHOX, NOX2, p91-PHOX | cytochrome b-245, beta polypeptide |
C00002689
|
2033 | EP300, KAT3B, RSTS2, p300 | E1A binding protein p300 (EC:2.3.1.48) |
C00002689
|
2335 | FN1, CIG, ED-B, FINC, FN, FNZ, GFND, GFND2, LETS, MSF | fibronectin 1 |
C00002689
|
1565 | CYP2D6, CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, CYPIID6, P450-DB1, P450C2D, P450DB1 | cytochrome P450, family 2, subfamily D, polypeptide 6 (EC:1.14.14.1) |
C00029961
|
27429 | HTRA2, OMI, PARK13, PRSS25 | HtrA serine peptidase 2 (EC:3.4.21.108) |
C00002689
|
3383 | ICAM1, BB2, CD54, P3.58 | intercellular adhesion molecule 1 |
C00002689
|
3456 | IFNB1, IFB, IFF, IFNB | interferon, beta 1, fibroblast |
C00002689
|
1559 | CYP2C9, CPC9, CYP2C, CYP2C10, CYPIIC9, P450IIC9 | cytochrome P450, family 2, subfamily C, polypeptide 9 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
C00029961
|
1558 | CYP2C8, CPC8, CYPIIC8, MP-12/MP-20 | cytochrome P450, family 2, subfamily C, polypeptide 8 (EC:1.14.14.1) |
C00029961
|
3684 | ITGAM, CD11B, CR3A, MAC-1, MAC1A, MO1A, SLEB6 | integrin, alpha M (complement component 3 receptor 3 subunit) |
C00002689
|
3717 | JAK2, JTK10, THCYT3 | Janus kinase 2 (EC:2.7.10.2) |
C00002689
|
3725 | JUN, AP-1, AP1, c-Jun | jun proto-oncogene |
C00002689
|
1557 | CYP2C19, CPCJ, CYP2C, P450C2C, P450IIC19 | cytochrome P450, family 2, subfamily C, polypeptide 19 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
C00029961
|
1548 | CYP2A6, CPA6, CYP2A, CYP2A3, CYPIIA6, P450C2A, P450PB | cytochrome P450, family 2, subfamily A, polypeptide 6 (EC:1.14.14.1) |
C00029961
|
4282 | MIF, GIF, GLIF, MMIF | macrophage migration inhibitory factor (glycosylation-inhibiting factor) (EC:5.3.3.12 5.3.2.1) |
C00002689
|
4322 | MMP13, CLG3, MANDP1 | matrix metallopeptidase 13 (collagenase 3) (EC:3.4.24.-) |
C00002689
|
4481 | MSR1, CD204, SCARA1, SR-A, SRA, phSR1, phSR2 | macrophage scavenger receptor 1 |
C00002689
|
653361 | NCF1, NCF1A, NOXO2, SH3PXD1A, p47phox | neutrophil cytosolic factor 1 |
C00002689
|
4792 | NFKBIA, IKBA, MAD-3, NFKBI | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
C00002689
|
4973 | OLR1, CLEC8A, LOX1, LOXIN, SCARE1, SLOX1 | oxidized low density lipoprotein (lectin-like) receptor 1 |
C00002689
|
1586 | CYP17A1, CPT7, CYP17, P450C17, S17AH | cytochrome P450, family 17, subfamily A, polypeptide 1 (EC:1.14.99.9 4.1.2.30) |
C00029961
|
5054 | SERPINE1, PAI, PAI-1, PAI1, PLANH1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
C00002689
|
6772 | STAT1, CANDF7, ISGF-3, STAT91 | signal transducer and activator of transcription 1, 91kDa |
C00002689
|
2023 | ENO1, ENO1L1, MPB1, NNE, PPH | enolase 1, (alpha) (EC:4.2.1.11) |
C00002668
|
7040 | TGFB1, CED, DPD1, LAP, TGFB, TGFbeta | transforming growth factor, beta 1 |
C00018099
|
7412 | VCAM1, CD106, INCAM-100 | vascular cell adhesion molecule 1 |
C00002689
|
5243 | ABCB1, ABC20, CD243, CLCS, GP170, MDR1, P-GP, PGY1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) |
C00002647
|
25 | ABL1, ABL, JTK7, bcr/abl, c-ABL, p150, v-abl | c-abl oncogene 1, non-receptor tyrosine kinase (EC:2.7.10.2) |
C00002647
|
4088 | SMAD3, HSPC193, HsT17436, JV15-2, LDS1C, LDS3, MADH3 | SMAD family member 3 |
C00018099
|
338 | APOB, FLDB, LDLCQ4 | apolipoprotein B |
C00002647
|
472 | ATM, AT1, ATA, ATC, ATD, ATDC, ATE, TEL1, TELO1 | ataxia telangiectasia mutated (EC:2.7.11.1) |
C00002647
|
545 | ATR, FCTCS, FRP1, MEC1, SCKL, SCKL1 | ataxia telangiectasia and Rad3 related (EC:2.7.11.1) |
C00002647
|
4087 | SMAD2, JV18, JV18-1, MADH2, MADR2, hMAD-2, hSMAD2 | SMAD family member 2 |
C00018099
|
6285 | S100B, NEF, S100, S100-B, S100beta | S100 calcium binding protein B |
C00018099
|
613 | BCR, ALL, BCR1, CML, D22S11, D22S662, PHL | breakpoint cluster region (EC:2.7.11.1) |
C00002647
|
177 | AGER, RAGE | advanced glycosylation end product-specific receptor |
C00018099
|
898 | CCNE1, CCNE | cyclin E1 |
C00002647
|
998 | CDC42, CDC42Hs, G25K | cell division cycle 42 |
C00002647
|
1027 | CDKN1B, CDKN4, KIP1, MEN1B, MEN4, P27KIP1 | cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
C00002647
|
1147 | CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16 | conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10) |
C00002647
|
7852 | CXCR4, CD184, D2S201E, FB22, HM89, HSY3RR, LAP3, LCR1, LESTR, NPY3R, NPYR, NPYRL, NPYY3R, WHIM | chemokine (C-X-C motif) receptor 4 |
C00002647
|
6319 | SCD, FADS5, MSTP008, SCD1, SCDOS | stearoyl-CoA desaturase (delta-9-desaturase) (EC:1.14.19.1) |
C00002743
|
356 | FASLG, ALPS1B, APT1LG1, APTL, CD178, CD95-L, CD95L, FASL, TNFSF6 | Fas ligand (TNF superfamily, member 6) |
C00002647
|
2551 | GABPA, E4TF1-60, E4TF1A, NFT2, NRF2, NRF2A, RCH04A07 | GA binding protein transcription factor, alpha subunit 60kDa |
C00002647
|
2885 | GRB2, ASH, EGFRBP-GRB2, Grb3-3, MST084, MSTP084, NCKAP2 | growth factor receptor-bound protein 2 |
C00002647
|
3551 | IKBKB, IKK-beta, IKK2, IKKB, NFKBIKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (EC:2.7.11.10) |
C00002647
|
3949 | LDLR, FH, FHC, LDLCQ2 | low density lipoprotein receptor |
C00002647
|
5604 | MAP2K1, CFC3, MAPKK1, MEK1, MKK1, PRKMK1 | mitogen-activated protein kinase kinase 1 (EC:2.7.12.2) |
C00002647
|
4255 | MGMT | O-6-methylguanine-DNA methyltransferase (EC:2.1.1.63) |
C00002647
|
4313 | MMP2, CLG4, CLG4A, MMP-II, MONA, TBE-1 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) |
C00002647
|
4316 | MMP7, MMP-7, MPSL1, PUMP-1 | matrix metallopeptidase 7 (matrilysin, uterine) (EC:3.4.24.23) |
C00002647
|
4318 | MMP9, CLG4B, GELB, MANDP2, MMP-9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) |
C00002647
|
4793 | NFKBIB, IKBB, TRIP9 | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta |
C00002647
|
5578 | PRKCA, AAG6, PKC-alpha, PKCA, PRKACA | protein kinase C, alpha (EC:2.7.11.13) |
C00002647
|
5925 | RB1, OSRC, RB, p105-Rb, pRb, pp110 | retinoblastoma 1 |
C00002743
|
5879 | RAC1, Rac-1, TC-25, p21-Rac1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) |
C00002647
|
19412 |
C00002647
|
||
387 | RHOA, ARH12, ARHA, RHO12, RHOH12 | ras homolog family member A |
C00002647
|
388 | RHOB, ARH6, ARHB, MST081, MSTP081, RHOH6 | ras homolog family member B |
C00002647
|
6195 | RPS6KA1, HU-1, MAPKAPK1A, RSK, RSK1 | ribosomal protein S6 kinase, 90kDa, polypeptide 1 (EC:2.7.11.1) |
C00002647
|
9252 | RPS6KA5, MSK1, MSPK1, RLPK | ribosomal protein S6 kinase, 90kDa, polypeptide 5 (EC:2.7.11.1) |
C00002647
|
5742 | PTGS1, COX1, COX3, PCOX1, PES-1, PGG/HS, PGHS-1, PGHS1, PHS1, PTGHS | prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00002743
|
23621 | BACE1, ASP2, BACE, HSPC104 | beta-site APP-cleaving enzyme 1 (EC:3.4.23.46) |
C00002743
|
7224 | TRPC5, TRP5 | transient receptor potential cation channel, subfamily C, member 5 |
C00002647
|
7422 | VEGFA, MVCD1, VEGF, VPF | vascular endothelial growth factor A |
C00002647
|
331 | XIAP, API3, BIRC4, IAP-3, ILP1, MIHA, XLP2, hIAP-3, hIAP3 | X-linked inhibitor of apoptosis |
C00002647
|
842 | CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56 | caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) |
C00002665
|
9518 | GDF15, GDF-15, MIC-1, MIC1, NAG-1, PDF, PLAB, PTGFB | growth differentiation factor 15 |
C00002665
|
2932 | GSK3B | glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) |
C00002665
|
142 | PARP1, ADPRT, ADPRT_1, ADPRT1, ARTD1, PARP, PARP-1, PPOL, pADPRT-1 | poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) |
C00002665
|
351 | APP, AAA, ABETA, ABPP, AD1, APPI, CTFgamma, CVAP, PN-II, PN2 | amyloid beta (A4) precursor protein |
C00002670
|
847 | CAT | catalase (EC:1.11.1.6) |
C00002670
|
10965 | ACOT2, CTE-IA, CTE1A, MTE1, PTE2, PTE2A, ZAP128 | acyl-CoA thioesterase 2 (EC:3.1.2.2) |
C00002664
|
174 | AFP, FETA, HPAFP | alpha-fetoprotein |
C00002664
|
213 | ALB, PRO0883, PRO0903, PRO1341 | albumin |
C00002664
|
249 | ALPL, AP-TNAP, APTNAP, HOPS, TNAP, TNSALP | alkaline phosphatase, liver/bone/kidney (EC:3.1.3.1) |
C00002664
|
25805 | BAMBI, NMA | BMP and activin membrane-bound inhibitor |
C00002664
|
8553 | BHLHE40, BHLHB2, DEC1, HLHB2, SHARP-2, STRA13, Stra14 | basic helix-loop-helix family, member e40 |
C00002664
|
10904 | BLCAP, BC10 | bladder cancer associated protein |
C00002664
|
813 | CALU | calumenin |
C00002664
|
890 | CCNA2, CCN1, CCNA | cyclin A2 |
C00002664
|
9469 | CHST3, C6ST, C6ST1, HSD | carbohydrate (chondroitin 6) sulfotransferase 3 (EC:2.8.2.17) |
C00002664
|
9076 | CLDN1, CLD1, ILVASC, SEMP1 | claudin 1 |
C00002664
|
1277 | COL1A1, OI4 | collagen, type I, alpha 1 |
C00002664
|
1385 | CREB1, CREB | cAMP responsive element binding protein 1 |
C00002664
|
100160140 |
C00002664
|
||
4051 | CYP4F3, CPF3, CYP4F, LTB4H | cytochrome P450, family 4, subfamily F, polypeptide 3 (EC:1.14.13.30) |
C00002664
|
26528 | DAZAP1 | DAZ associated protein 1 |
C00002664
|
55802 | DCP1A, HSA275986, Nbla00360, SMAD4IP1, SMIF | decapping mRNA 1A |
C00002664
|
1654 | DDX3X, DBX, DDX14, DDX3, HLP2 | DEAD (Asp-Glu-Ala-Asp) box helicase 3, X-linked (EC:3.6.4.13) |
C00002664
|
1843 | DUSP1, CL100, HVH1, MKP-1, MKP1, PTPN10 | dual specificity phosphatase 1 (EC:3.1.3.16 3.1.3.48) |
C00002664
|
22936 | ELL2 | elongation factor, RNA polymerase II, 2 |
C00002664
|
2099 | ESR1, ER, ESR, ESRA, ESTRR, Era, NR3A1 | estrogen receptor 1 |
C00002664
|
2114 | ETS2, ETS2IT1 | v-ets avian erythroblastosis virus E26 oncogene homolog 2 |
C00002664
|
355 | FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6 | Fas cell surface death receptor |
C00002664
|
26190 | FBXW2, FBW2, Fwd2, Md6 | F-box and WD repeat domain containing 2 |
C00002664
|
8061 | FOSL1, FRA, FRA1, fra-1 | FOS-like antigen 1 |
C00002664
|
2624 | GATA2, DCML, MONOMAC, NFE1B | GATA binding protein 2 |
C00002664
|
9329 | GTF3C4, KAT12, TFIII90, TFIIIC290, TFIIIC90, TFIIICDELTA | general transcription factor IIIC, polypeptide 4, 90kDa (EC:2.3.1.48) |
C00002664
|
3014 | H2AFX, H2A.X, H2A/X, H2AX | H2A histone family, member X |
C00002664
|
26762 | HAVCR1, HAVCR, HAVCR-1, KIM-1, KIM1, TIM, TIM-1, TIM1, TIMD-1, TIMD1 | hepatitis A virus cellular receptor 1 |
C00002664
|
3280 | HES1, HES-1, HHL, HRY, bHLHb39 | hes family bHLH transcription factor 1 |
C00002664
|
3188 | HNRNPH2, FTP3, HNRPH', HNRPH2, hnRNPH' | heterogeneous nuclear ribonucleoprotein H2 (H') |
C00002664
|
3399 | ID3, HEIR-1, bHLHb25 | inhibitor of DNA binding 3, dominant negative helix-loop-helix protein |
C00002664
|
3552 | IL1A, IL-1A, IL1, IL1-ALPHA, IL1F1 | interleukin 1, alpha |
C00002664
|
54556 | ING3, Eaf4, ING2, MEAF4, p47ING3 | inhibitor of growth family, member 3 |
C00002664
|
7071 | KLF10, EGR-alpha, EGRA, TIEG, TIEG1 | Kruppel-like factor 10 |
C00002664
|
1316 | KLF6, BCD1, CBA1, COPEB, CPBP, GBF, PAC1, ST12, ZF9 | Kruppel-like factor 6 |
C00002664
|
3840 | KPNA4, IPOA3, QIP1, SRP3 | karyopherin alpha 4 (importin alpha 3) |
C00002664
|
4041 | LRP5, BMND1, EVR1, EVR4, HBM, LR3, LRP7, OPPG, OPS, OPTA1, VBCH2 | low density lipoprotein receptor-related protein 5 |
C00002664
|
10905 | MAN1A2, MAN1B | mannosidase, alpha, class 1A, member 2 (EC:3.2.1.113) |
C00002664
|
4170 | MCL1, BCL2L3, EAT, MCL1-ES, MCL1L, MCL1S, Mcl-1, TM, bcl2-L-3, mcl1/EAT | myeloid cell leukemia sequence 1 (BCL2-related) |
C00002664
|
4247 | MGAT2, CDG2A, CDGS2, GLCNACTII, GNT-II, GNT2 | mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase (EC:2.4.1.143) |
C00002664
|
4353 | MPO | myeloperoxidase (EC:1.11.2.2) |
C00002664
|
740 | MRPL49, C11orf4, L49mt, MRP-L49, NOF, NOF1 | mitochondrial ribosomal protein L49 |
C00002664
|
4496 | MT1H, MT-0, MT-1H, MT-IH, MT1 | metallothionein 1H |
C00002664
|
4501 | MT1X, MT-1l, MT1 | metallothionein 1X |
C00002664
|
4778 | NFE2, NF-E2, p45 | nuclear factor, erythroid 2 |
C00002664
|
4790 | NFKB1, EBP-1, KBF1, NF-kB1, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, NFkappaB, p105, p50 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
C00002664
|
4800 | NFYA, CBF-A, CBF-B, HAP2, NF-YA | nuclear transcription factor Y, alpha |
C00002664
|
8431 | NR0B2, SHP, SHP1 | nuclear receptor subfamily 0, group B, member 2 |
C00002664
|
57162 | PELI1 | pellino E3 ubiquitin protein ligase 1 |
C00002664
|
8864 | PER2, FASPS, FASPS1 | period circadian clock 2 |
C00002664
|
5293 | PIK3CD, P110DELTA, PI3K, p110D | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta (EC:2.7.1.153) |
C00002664
|
5292 | PIM1, PIM | pim-1 oncogene (EC:2.7.11.1) |
C00002664
|
9240 | PNMA1, MA1 | paraneoplastic Ma antigen 1 |
C00002664
|
5411 | PNN, DRS, DRSP, SDK3, memA | pinin, desmosome associated protein |
C00002664
|
10908 | PNPLA6, NTE, NTEMND, SPG39, iPLA2delta, sws | patatin-like phospholipase domain containing 6 (EC:3.1.1.5) |
C00002664
|
5468 | PPARG, CIMT1, GLM1, NR1C3, PPARG1, PPARG2, PPARgamma | peroxisome proliferator-activated receptor gamma |
C00002664
|
8493 | PPM1D, PP2C-DELTA, WIP1 | protein phosphatase, Mg2+/Mn2+ dependent, 1D (EC:3.1.3.16) |
C00002664
|
38175 |
C00002664
|
||
9367 | RAB9A, RAB9 | RAB9A, member RAS oncogene family |
C00002664
|
29803 | REPIN1, AP4, RIP60, ZNF464, Zfp464 | replication initiator 1 |
C00002664
|
10670 | RRAGA, FIP-1, FIP1, RAGA | Ras-related GTP binding A |
C00002664
|
51282 | SCAND1, RAZ1, SDP1 | SCAN domain containing 1 |
C00002664
|
22928 | SEPHS2, SPS2, SPS2b | selenophosphate synthetase 2 (EC:2.7.9.3) |
C00002664
|
150094 | SIK1, MSK, SIK, SNF1LK | salt-inducible kinase 1 (EC:2.7.11.1) |
C00002664
|
23411 | SIRT1, SIR2L1 | sirtuin 1 |
C00002664
|
9990 | SLC12A6, ACCPN, KCC3, KCC3A, KCC3B | solute carrier family 12 (potassium/chloride transporter), member 6 |
C00002664
|
6426 | SRSF1, ASF, SF2, SF2p33, SFRS1, SRp30a | serine/arginine-rich splicing factor 1 |
C00002664
|
6430 | SRSF5, HRS, SFRS5, SRP40 | serine/arginine-rich splicing factor 5 |
C00002664
|
51188 | SS18L2, KIAA-iso | synovial sarcoma translocation gene on chromosome 18-like 2 |
C00002664
|
6879 | TAF7, TAF2F, TAFII55 | TAF7 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 55kDa |
C00002664
|
23435 | TARDBP, ALS10, TDP-43 | TAR DNA binding protein |
C00002664
|
10732 | TCFL5, CHA, E2BP-1, Figlb, bHLHe82 | transcription factor-like 5 (basic helix-loop-helix) |
C00002664
|
7014 | TERF2, TRBF2, TRF2 | telomeric repeat binding factor 2 |
C00002664
|
7050 | TGIF1, HPE4, TGIF | TGFB-induced factor homeobox 1 |
C00002664
|
6351 | CCL4, ACT2, AT744.1, G-26, HC21, LAG-1, LAG1, MIP-1-beta, MIP1B, MIP1B1, SCYA2, SCYA4 | chemokine (C-C motif) ligand 4 |
C00002644
|
7128 | TNFAIP3, A20, OTUD7C, TNFA1P2 | tumor necrosis factor, alpha-induced protein 3 (EC:3.4.19.12) |
C00002664
|
27242 | TNFRSF21, BM-018, CD358, DR6 | tumor necrosis factor receptor superfamily, member 21 |
C00002664
|
10140 | TOB1, APRO6, PIG49, TOB, TROB, TROB1 | transducer of ERBB2, 1 |
C00002664
|
10221 | TRIB1, C8FW, GIG-2, GIG2, SKIP1, TRB-1, TRB1 | tribbles pseudokinase 1 |
C00002664
|
7286 | TUFT1 | tuftelin 1 |
C00002664
|
595 | CCND1, BCL1, D11S287E, PRAD1, U21B31 | cyclin D1 |
C00002743
|
7357 | UGCG, GCS, GLCT1 | UDP-glucose ceramide glucosyltransferase (EC:2.4.1.80) |
C00002664
|
8876 | VNN1, HDLCQ8, Tiff66 | vanin 1 (EC:3.5.1.92) |
C00002664
|
7444 | VRK2 | vaccinia related kinase 2 (EC:2.7.11.1) |
C00002664
|
231 | AKR1B1, ADR, ALDR1, ALR2, AR | aldo-keto reductase family 1, member B1 (aldose reductase) (EC:1.1.1.21) |
C00000207
|
57016 | AKR1B10, AKR1B11, AKR1B12, ALDRLn, ARL-1, ARL1, HIS, HSI | aldo-keto reductase family 1, member B10 (aldose reductase) (EC:1.1.1.2) |
C00000207
|
1645 | AKR1C1, 2-ALPHA-HSD, 20-ALPHA-HSD, C9, DD1, DD1/DD2, DDH, DDH1, H-37, HAKRC, HBAB, MBAB | aldo-keto reductase family 1, member C1 (EC:1.3.1.20 1.1.1.149 1.1.1.112) |
C00000207
|
8644 | AKR1C3, DD3, DDX, HA1753, HAKRB, HAKRe, HSD17B5, PGFS, hluPGFS | aldo-keto reductase family 1, member C3 (EC:1.3.1.20 1.1.1.188 1.1.1.239 1.1.1.64 1.1.1.112 1.1.1.357) |
C00000207
|
2235 | FECH, EPP, FCE | ferrochelatase (EC:4.99.1.1) |
C00000207
|
2512 | FTL, NBIA3 | ferritin, light polypeptide |
C00000207
|
2539 | G6PD, G6PD1 | glucose-6-phosphate dehydrogenase (EC:1.1.1.49) |
C00000207
|
2729 | GCLC, GCL, GCS, GLCL, GLCLC | glutamate-cysteine ligase, catalytic subunit (EC:6.3.2.2) |
C00000207
|
2730 | GCLM, GLCLR | glutamate-cysteine ligase, modifier subunit (EC:6.3.2.2) |
C00000207
|
2936 | GSR | glutathione reductase (EC:1.8.1.7) |
C00000207
|
2938 | GSTA1, GST2, GSTA1-1, GTH1 | glutathione S-transferase alpha 1 (EC:2.5.1.18) |
C00000207
|
4097 | MAFG, hMAF | v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog G |
C00000207
|
4199 | ME1, HUMNDME, MES | malic enzyme 1, NADP(+)-dependent, cytosolic (EC:1.1.1.40) |
C00000207
|
4489 | MT1A, MT1, MT1S, MTC | metallothionein 1A |
C00000207
|
4502 | MT2A, MT2 | metallothionein 2A |
C00000207
|
5226 | PGD, 6PGD | phosphogluconate dehydrogenase (EC:1.1.1.44) |
C00000207
|
22949 | PTGR1, LTB4DH, PGR1, ZADH3 | prostaglandin reductase 1 (EC:1.3.1.48 1.3.1.74) |
C00000207
|
6566 | SLC16A1, HHF7, MCT, MCT1 | solute carrier family 16 (monocarboxylate transporter), member 1 |
C00000207
|
140809 | SRXN1, C20orf139, Npn3, SRX, SRX1 | sulfiredoxin 1 (EC:1.8.98.2) |
C00000207
|
7295 | TXN, TRDX, TRX, TRX1 | thioredoxin |
C00000207
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#614279 | 46,xy sex reversal 8; srxy8 |
P17516
P52895 |
#100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#103470 | Albinism, ocular, with sensorineural deafness |
P14679
|
#203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
#606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
#103780 | Alcohol dependence |
P08172
P14416 P31645 |
#614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
#300068 | Androgen insensitivity syndrome; ais |
P10275
|
#312300 | Androgen insensitivity, partial; pais |
P10275
|
#600807 | Asthma, susceptibility to |
Q13093
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#601816 | Bilirubin, serum level of, quantitative trait locus 1; biliqtl1 |
P22309
|
#210900 | Bloom syndrome; blm |
P54132
|
#602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
%606641 | Body mass index; bmi |
P37231
|
#300615 | Brunner syndrome |
P21397
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#609338 | Carotid intimal medial thickness 1 |
P37231
|
#118300 | Charcot-marie-tooth disease and deafness |
Q01453
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#118220 | Charcot-marie-tooth disease, demyelinating, type 1a; cmt1a |
Q01453
|
#614466 | Coronary heart disease, susceptibility to, 6; chds6 |
P08254
|
#218800 | Crigler-najjar syndrome, type i |
P22309
P22310 |
#606785 | Crigler-najjar syndrome, type ii |
P22309
P22310 |
#162800 | Cyclic neutropenia |
P08246
|
#612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
#119900 | Digital clubbing, isolated congenital |
P15428
|
#607208 | Dravet syndrome |
P18507
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#607681 | Epilepsy, childhood absence, susceptibility to, 2; eca2 |
P18507
|
#611136 | Epilepsy, juvenile myoclonic, susceptibility to, 5; ejm5 |
P14867
|
#609820 | Erythrocytosis, familial, 3; ecyt3 |
Q9GZT9
|
#133239 | Esophageal cancer |
P04637
|
#615363 | Estrogen resistance; estrr |
P03372
|
#301500 | Fabry disease |
P06280
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#230000 | Fucosidosis |
P04066
|
#613163 | Gaba-transaminase deficiency |
P80404
|
#613659 | Gastric cancer |
P04626
|
#137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
#604233 | Generalized epilepsy with febrile seizures plus, type 1; gefsp1 |
P18507
|
#611277 | Generalized epilepsy with febrile seizures plus, type 3; gefsp3 |
P18507
|
#231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
#143500 | Gilbert syndrome |
P22309
P22310 |
#137800 | Glioma susceptibility 1; glm1 |
O75874
P04626 P37231 |
#232300 | Glycogen storage disease ii |
P10253
|
#139393 | Guillain-barre syndrome, familial; gbs |
Q01453
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#614519 | Hemorrhage, intracerebral, susceptibility to; ich |
P12821
|
#114550 | Hepatocellular carcinoma |
P08581
|
#609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
#143100 | Huntington disease; hd |
P42858
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#237900 | Hyperbilirubinemia, transient familial neonatal; hblrtfn |
P22309
|
#143860 | Hyperchlorhidrosis, isolated |
O43570
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#145900 | Hypertrophic neuropathy of dejerine-sottas |
Q01453
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#147050 | Ige responsiveness, atopic; iger |
Q13093
|
#614328 | Inflammatory skin and bowel disease, neonatal; nisbd |
P78536
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#607785 | Juvenile myelomonocytic leukemia; jmml |
Q06124
|
#151100 | Leopard syndrome 1 |
Q06124
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#604367 | Lipodystrophy, familial partial, type 3; fpld3 |
P37231
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P00533
P04626 P04637 |
#608516 | Major depressive disorder; mdd |
P08172
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
%300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#156250 | Metachondromatosis; metcds |
Q06124
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#612624 | Microvascular complications of diabetes, susceptibility to, 3; mvcd3 |
P12821
|
#601492 | Mucopolysaccharidosis, type ix; mps9 |
Q12794
|
#259600 | Multicentric osteolysis, nodulosis, and arthropathy; mona |
P08253
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#159900 | Myoclonic dystonia |
P14416
|
#162500 | Neuropathy, hereditary, with liability to pressure palsies; hnpp |
Q01453
|
#202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
#257200 | Niemann-pick disease, type a |
P17405
|
#607616 | Niemann-pick disease, type b |
P17405
|
#257220 | Niemann-pick disease, type c1; npc1 |
O15118
|
#163950 | Noonan syndrome 1; ns1 |
Q06124
|
#601665 | Obesity |
P32245
P37231 |
#164230 | Obsessive-compulsive disorder; ocd |
P31645
|
#604715 | Orthostatic intolerance |
P23975
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P04626
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
#172700 | Pick disease of brain |
P10636
|
#601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
#614278 | Platelet-activating factor acetylhydrolase deficiency; pafad |
Q13093
|
#605074 | Renal cell carcinoma, papillary, 1; rccp1 |
P08581
|
#267430 | Renal tubular dysgenesis; rtd |
P12821
|
#607276 | Resting heart rate, variation in |
P08588
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#600852 | Retinitis pigmentosa 17; rp17 |
P22748
|
#604906 | Schizophrenia 9; sczd9 |
P49798
|
#181500 | Schizophrenia; sczd |
P49798
|
#608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
#313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
#601367 | Stroke, ischemic |
P12821
P16109 |
#271980 | Succinic semialdehyde dehydrogenase deficiency; ssadhd |
P51649
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#610460 | Thiopurine s-methyltransferase deficiency |
P51580
|
#187950 | Thrombocythemia 1; thcyt1 |
P40225
|
#188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
#274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
#145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
#610379 | West nile virus, susceptibility to |
P51681
|
#278300 | Xanthinuria, type i |
P47989
|
#278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00136 | Niemann-Pick disease type C (NPC) |
O15118
(related)
|
H01302 | Hyperchlorhidrosis isolated (HCHLH) |
O43570
(related)
|
H00021 | Renal cell carcinoma |
O43570
(marker)
P04637 (marker) P08581 (related) Q16790 (marker) |
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00017 | Esophageal cancer |
P00533
(related)
P04637 (related) P04637 (marker) P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04626 (related) P04637 (related) P08581 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04626 (related) P04637 (related) |
H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) P04637 (related) P08253 (related) |
H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
H00042 | Glioma |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
Q01453 (related) |
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
P37231 (related) |
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) P04637 (related) Q92731 (marker) |
H00141 | Fucosidosis |
P04066
(related)
|
H00422 | Glycoproteinoses |
P04066
(related)
|
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
H00019 | Pancreatic cancer |
P04626
(related)
P04637 (related) P04637 (marker) |
H00027 | Ovarian cancer |
P04626
(related)
P04637 (related) |
H00031 | Breast cancer |
P04626
(related)
P04626 (marker) P04637 (related) |
H00046 | Cholangiocarcinoma |
P04626
(related)
P04637 (related) P08581 (related) P35354 (related) |
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
Q01196 (related) |
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) P08253 (related) P14780 (related) P35354 (related) |
H00029 | Vulvar cancer |
P04637
(related)
|
H00032 | Thyroid cancer |
P04637
(related)
P37231 (related) |
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
P14679 (marker) |
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00125 | Fabry disease |
P06280
(related)
|
H00079 | Asthma |
P07550
(related)
|
H00100 | Neutropenic disorders |
P08246
(related)
|
H00472 | Torg-Winchester syndrome |
P08253
(related)
|
H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
H00024 | Prostate cancer |
P10275
(related)
|
H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00083 | Allograft rejection |
P12821
(related)
|
H00575 | Renal tubular dysgenesis |
P12821
(related)
|
H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
H00479 | Metaphyseal dysplasias |
P14780
(related)
|
H00808 | Idiopathic generalized epilepsies (IGEs) |
P14867
(related)
P18507 (related) |
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H00137 | Niemann-Pick disease (NPD) typeA and B |
P17405
(related)
|
H00424 | Defects in the degradation of sphingomyelin |
P17405
(related)
|
H00783 | Febrile seizures |
P18507
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H00208 | Hyperbilirubinemia |
P22309
(related)
|
H00527 | Retinitis pigmentosa (RP) |
P22748
(related)
|
H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00409 | Type II diabetes mellitus |
P37231
(related)
|
H00227 | Congenital amegakaryocytic thrombocytopenia (CAMT) |
P40225
(marker)
|
H00059 | Huntington's disease (HD) |
P42858
(related)
|
H00192 | Xanthinuria |
P47989
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
Q99714 (related) |
H00964 | Thiopurine S-methyltransferase deficiency (TPMT deficiency) |
P51580
(related)
|
H00835 | Succinic semialdehyde dehydrogenase (SSADH) deficiency |
P51649
(related)
|
H00094 | DNA repair defects |
P54132
(related)
|
H00296 | Defects in RecQ helicases |
P54132
(related)
|
H01257 | GABA-transaminase deficiency |
P80404
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) Q03164 (related) Q03164 (marker) |
H00003 | Acute myeloid leukemia (AML) |
Q01196
(related)
Q01196 (marker) Q13951 (marker) |
H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
H01296 | Hereditary neuropathy with liability to pressure palsies (HNPP) |
Q01453
(related)
|
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00523 | Noonan syndrome and related disorders |
Q06124
(related)
|
H01018 | Metachondromatosis |
Q06124
(related)
|
H00133 | Mucopolysaccharidosis type IX (MPS9) |
Q12794
(related)
|
H00421 | Mucopolysaccharidosis (MPS) |
Q12794
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
Q9NUW8 (related) |
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
H00236 | Congenital polycythemia |
Q9GZT9
(related)
|
H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D048629 | Micronuclei, Chromosome-Defective |
C00002644
C00002670 C00002664 |
D006973 | Hypertension |
C00002689
C00002664 |
D004487 | Edema |
C00002776
C00002664 |
D056486 | Drug-Induced Liver Injury |
C00002776
C00002670 |
D003877 | Dermatitis, Contact |
C00002664
C00000207 |
D009203 | Myocardial Infarction |
C00002743
C00002647 |
D011041 | Poisoning |
C00002644
C00002664 |
D009784 | Occupational Diseases |
C00002644
C00002664 |
D008545 | Melanoma |
C00002743
C00029961 |
D006949 | Hyperlipidemias |
C00002647
|
D003384 | Coxsackievirus Infections |
C00029961
|
D048909 | Diabetes Complications |
C00018099
|
D002386 | Cataract |
C00018099
|
D012640 | Seizures |
C00002644
|
D012220 | Rhinitis |
C00000856
|
D000419 | Albuminuria |
C00002689
|
D001919 | Bradycardia |
C00002689
|
D020520 | Brain Infarction |
C00002689
|
D002310 | Cardiomyopathy, Alcoholic |
C00002689
|
D003928 | Diabetic Nephropathies |
C00002689
|
D006331 | Heart Diseases |
C00002689
|
D050197 | Atherosclerosis |
C00002743
|
D007022 | Hypotension |
C00002689
|
D009410 | Nerve Degeneration |
C00002689
|
D011014 | Pneumonia |
C00002689
|
D000647 | Amnesia |
C00002776
|
D000860 | Anoxia |
C00002776
|
D001930 | Brain Injuries |
C00002776
|
D008106 | Liver Cirrhosis, Experimental |
C00002743
|
D007249 | Inflammation |
C00002743
|
D003921 | Diabetes Mellitus, Experimental |
C00002647
|
D050171 | Dyslipidemias |
C00002647
|
D005234 | Fatty Liver |
C00002647
|
D018149 | Glucose Intolerance |
C00002647
|
D006937 | Hypercholesterolemia |
C00002647
|
D006943 | Hyperglycemia |
C00002647
|
D002869 | Chromosome Aberrations |
C00002644
|
D015228 | Hypertriglyceridemia |
C00002647
|
D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
C00002647
|
D008546 | Melanoma, Experimental |
C00002647
|
D009069 | Movement Disorders |
C00002647
|
D009361 | Neoplasm Invasiveness |
C00002647
|
D009362 | Neoplasm Metastasis |
C00002647
|
D012516 | Osteosarcoma |
C00002647
|
D010182 | Pancreatic Diseases |
C00002647
|
D011832 | Radiation Injuries |
C00002665
|
D013959 | Thyroid Diseases |
C00002665
|
D058186 | Acute Kidney Injury |
C00002664
|
D001855 | Bone Marrow Diseases |
C00002664
|
D001859 | Bone Neoplasms |
C00002664
|
D001913 | Bowen's Disease |
C00002664
|
D003128 | COMA |
C00002664
|
D003556 | Cystitis |
C00002664
|
D017449 | Dermatitis, Allergic Contact |
C00002664
|
D002252 | Carbon Tetrachloride Poisoning |
C00002743
|
D004382 | Duodenitis |
C00002664
|
D005756 | Gastritis |
C00002664
|
D006417 | Hematuria |
C00002664
|
D006470 | Hemorrhage |
C00002664
|
D007035 | Hypothermia |
C00002664
|
D055623 | Keratosis, Actinic |
C00002664
|
D010146 | Pain |
C00002664
|
D020734 | Parkinsonian Disorders |
C00002664
|
D010392 | Pemphigus |
C00002664
|
D010523 | Peripheral Nervous System Diseases |
C00002664
|
D010864 | Pilonidal Sinus |
C00002664
|
D012131 | Respiratory Insufficiency |
C00002664
|
D013088 | Spermatocele |
C00002664
|
D006848 | Testicular Hydrocele |
C00002664
|
D014202 | Tremor |
C00002664
|
D014277 | Trigeminal Neuralgia |
C00002664
|
D014860 | Warts |
C00002664
|